Acquired Immunodeficiency Syndrome
150
1
2
132
Key Insights
Highlights
Success Rate
99% trial completion (above average)
Published Results
24 trials with published results (16%)
Research Maturity
132 completed trials (88% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
1.3%
2 terminated out of 150 trials
98.5%
+12.0% vs benchmark
21%
32 trials in Phase 3/4
18%
24 of 132 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 132 completed trials
Clinical Trials (150)
Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults
Managing Hypertension Among People Living With HIV
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men
Community Intervention for HIV Testing & Care Linkage Among Young MSM in Bulgaria
Technological Intervention for Reducing Alcohol Use Among People Living With HIV/AIDS
A Multicenter Prospective Clinical Cohort Study on the Pathogen Spectrum of HIV/AIDS Complicated With Infection
Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia
Clinic-based ART Diagnostic Evaluation
Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City
A Unified Intervention for Young Gay and Bisexual Men's Minority Stress, Mental Health, and HIV Risk
Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED)
Efficacy and Tolerability of DTG Plus 3TC in HIV Infected Adults With Virologically Suppression and TDF Toxicity
Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer
POC Strategies to Improve TB Care in Advanced HIV Disease
HIV Indicator Diseases in Hospital and Primary Care
Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection
Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea
Stanford Universities: The Stanford HIV Aging Cohort
HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)